KISSEI PHARMACEUTICAL CO.,LTD. 4547Short Interest
No institution currently reports a short position of 0.5% or more in KISSEI PHARMACEUTICAL CO.,LTD. (4547). The last disclosure was on 2026-10-01 (Citigroup Global Markets Limited, 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
6 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2026-02-19 |
|---|---|
| Latest disclosure | 2026-10-01 (Citigroup Global Markets Limited, 0.49%) |
| Reporting institutions | 2 firms (6 reports) |
| Peak estimated short interest | 0.61% (2026-02-24, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 2 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Morgan Stanley MUFG Securities Co., Ltd.
- Citigroup Global Markets Limited
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-10-01 | Citigroup Global Markets Limited | Position 232,300 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-03-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 227,986 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
Disclosure History 6 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-01 | Citigroup Global Markets Limited | Position 232,300 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-09-10 | Citigroup Global Markets Limited | Position 232,900 shares | Ratio 0.50% | ▲0.02% | — |
| 2026-03-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 227,986 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-03-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 278,186 shares | Ratio 0.59% | ▼0.02% | — |
| 2026-02-24 | Morgan Stanley MUFG Securities Co., Ltd. | Position 288,196 shares | Ratio 0.61% | ▲0.09% | — |
| 2026-02-19 | Morgan Stanley MUFG Securities Co., Ltd. | Position 244,296 shares | Ratio 0.52% | ▲0.12% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |